Article
XRCC1 and XPD polymorphisms: clinical outcomes and risk of prostate cancer in Bangladeshi population.
Molecular biology reports - 8 Aug 2024
Ahmed Nafisa, Islam Md Ariful, Hossain M Mahboob, Kabir Yearul
Abstract excerpt
BACKGROUND: In Bangladesh, only a fraction of prostate cancer patients are diagnosed annually due to lack of symptom awareness and screening challenges, resulting in high mortality. Aiming to improve screening methods, we evaluated X-ray cross-complementing gene 1 (XRCC1) Arg194Gln and Xeroderma pigmentosum group D (XPD) Lys751Gln polymorphisms to determine their relevance as potential markers for predicting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
